Home
Company
Services
Staffing
Facilities
News
Contact Us

RECENT NEWS     April 16, 2008    

  KAR Bioanalytical, Inc.

•  New equipment update

  	New API 3000 (Sciex) LC/MS/MS - 04/2008 - Triple Quadrupole Liquid Chromatograph-Mass Spectrometer coupled to a new Waters 2975 HPLC.  This is an identical setup to our existing API 3000 system which will add redundancy and increased capacity to the Pharmaceutical Laboratory.
  	New Thermo Spectronic Genesys 20 Spectrophotometer - 09/2006 - An additional Model 4001/4 has been purchased for routine production testing and will provide redundancy for our first Genesys 20 system.
  	New API 3000 (Sciex) LC/MS/MS - 10/2004 - Triple Quadrupole Liquid Chromatograph-Mass Spectrometer.  Bringing enhanced sensitivity and increased throughput to the Pharmaceutical Laboratory.
  	New Thermo Finnigan Trace DSQ GC-MS - 09/04 - Ordered for the Semi-Volatiles Laboratory, this instrument has a Large Volume Injector, Vacuum Probe Interlock, TriPlus Autosampler, and the NIST Mass Spectral Library.  Additionally, Prolab Resource Plus ChemStation software was purchased to facilitate 21CFR Part 11 compliance (for GLP).

• Three Professionals Recently Added to Staff  - 2/11/2008 - Terry Podoll, Ph.D. will take over management and research responsibilities in the Pharmaceutical laboratories.  Terry has over 11 years of hands on analytical chemistry, project management, and study director experience at three industry-leading drug research companies.  2/25/2008 - Two chemists have also accepted job offers and will be joining the KAR Bio team, starting the week of 3/10.

• MDEQ Hazardous Waste Inspection  - 7/27/2007 - An unannounced hazardous waste inspection and audit from the Michigan Department of Environmental Quality (MDEQ) took place today.  There were no findings, and the auditor said that it's a pleasure to inspect a facility where everything is being done correctly. We should receive an "in compliance" letter within the next few weeks. Congratulations to KAR Laboratories, Inc. staff of Dave Alkema CHMM (Certified Hazardous Materials Manager), Safety Officer Julie Rumsey, and Chemist Mike Walsh for their diligence in weekly waste handling, inspecting, and recordkeeping.

• Pharmaceuticals Laboratory Division Spin-off - 7/1/2007 - The drug research laboratory section has been designated as its' own company.  Keeping the same location, all of the same shareholders, directors, and officers, as a practical matter not much has really changed.  The spin-off will allow better management by tracking each of the individual company's performance separately.

• Anniversary Celebrations -  11-2-06 - Jayne Rauch, 10 years of service.  04-26-06 - Mark Zwiefka, 15 years of service.   03/17/05 - Bill Rauch, 20 years of service.  Anniversary celebrations include cake and a gift certificate to a hotel or Bed & Breakfast of their choice, plus an engraved plaque (10 years), engraved desk clock (15 years), or engraved Swiss-made wristwatch (20 years).

•  Why are drugs so expensive? -  06/28/05 - Radio talk show host Paul Harvey recently commented about getting one new drug to market in the U.S.   On average, it takes 10 to 15 years, costs 900 million dollars (about what it cost to put a man on the moon), and has a 1 in 5000 chance of success, about the same odds as a golfer getting a hole in one.

•  

  Miron Communications Group, LLC in affiliation with Biggs|Gilmore, selected KAR Bioanalytical to showcase the Mobile Technology Benches from Flexible Furniture. Photos will be used in Flexible Furniture’s promotional literature featuring KAR scientists and equipment.

• Audit - 2/3/2005 -  The U.S. Food and Drug Administration, Detroit District, conducted a routine, unannounced 3-day facilities inspection and records audit. Result: No significant findings and no 483 citations, which is the best possible result a laboratory can achieve.

•  KAR lead the way in quality performance - 1/05 - In the most recent National Environmental Water Pollution Proficiency Test among 294 laboratories graded, KAR achieved a 99.72% rating, good for a 3rd place national ranking.  Click here to see KAR Laboratories, Inc.industry-leading blind sample history.